Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Guijarro

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Circulation|November 28, 2001
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular diseaseC Guijarro
Revista De Neurologia|September 10, 2019
[Metronidazole-induced encephalopathy: description of a case with radiological and anatomopathological findings]C Guijarro-Castro
Revista Clinica Espanola|July 9, 2019
PCSK9 inhibitors: Ratification of the role of LDL cholesterol in cardiovascular prevention. Towards a convergence of European and North American prevention guidelines?C Guijarro, M Camafort
Revista Clinica Espanola|January 15, 2020
COPD and cardiovascular disease: More than just a co-incidenceX Pena, C Guijarro
JAMA|May 18, 2000
Elevated liver enzymes following initiation of antiretroviral therapyM Velasco, C Guijarro
The New England Journal of Medicine|June 23, 2001
Expenditures for the care of patients with HIVM Velasco, C Guijarro
Kidney International|February 13, 2001
Transcription factor-kappa B (NF-kappa B) and renal diseaseC Guijarro, J Egido
Revista Clinica Espanola|September 26, 2021
Estimation of vascular risk: Time and place matterJ I Cuende, C Guijarro
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|July 19, 2002
[Cardiovascular risk and dyslipidemia after renal transplantation]C Guijarro, Z A Massu
Medicina Clinica|October 21, 1995
[Hyperlipidemia and nephropathy: cause or consequence?]C Guijarro, W F Keane
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Circulation|November 28, 2001
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular diseaseC Guijarro
Revista De Neurologia|September 10, 2019
[Metronidazole-induced encephalopathy: description of a case with radiological and anatomopathological findings]C Guijarro-Castro
Revista Clinica Espanola|July 9, 2019
PCSK9 inhibitors: Ratification of the role of LDL cholesterol in cardiovascular prevention. Towards a convergence of European and North American prevention guidelines?C Guijarro, M Camafort
Revista Clinica Espanola|January 15, 2020
COPD and cardiovascular disease: More than just a co-incidenceX Pena, C Guijarro
JAMA|May 18, 2000
Elevated liver enzymes following initiation of antiretroviral therapyM Velasco, C Guijarro
The New England Journal of Medicine|June 23, 2001
Expenditures for the care of patients with HIVM Velasco, C Guijarro
Kidney International|February 13, 2001
Transcription factor-kappa B (NF-kappa B) and renal diseaseC Guijarro, J Egido
Revista Clinica Espanola|September 26, 2021
Estimation of vascular risk: Time and place matterJ I Cuende, C Guijarro
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|July 19, 2002
[Cardiovascular risk and dyslipidemia after renal transplantation]C Guijarro, Z A Massu
Medicina Clinica|October 21, 1995
[Hyperlipidemia and nephropathy: cause or consequence?]C Guijarro, W F Keane
Pageof 10